Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Azathioprine may be an effective treatment for severe hair loss.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

A man with severe hair loss regrew hair after hormone treatment.

A mutation in the human hairless gene causes alopecia universalis.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Tofacitinib may help treat severe hair loss, but more research is needed.

Topical Ruxolitinib may safely treat severe hair loss.

A specific gene change is linked to severe hair loss.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Immune recovery after HIV treatment can cause autoimmune issues like hair loss and thyroid disease.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Diphencyprone therapy for hair loss can cause vitiligo.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Early-onset alopecia, especially with a family history, leads to worse outcomes and more related health issues.

DPCP is more effective than tretinoin gel for treating severe alopecia.

No systemic causes were found for the patients' conditions.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.